SK Life Science starts TV ad campaign to drive patients to seizure drug Xcopri
SK Life Science is encouraging patients beetling down the long and winding road toward seizure-free life to switch gears. In a new nationwide direct-to-consumer ad, the Xcopri manufacturer asks partial-onset seizure patients to consider switching to a new treatment.
SK Life Science is encouraging patients beetling down the long and winding road toward seizure-free life to switch gears. In a new nationwide direct-to-consumer ad, the Xcopri manufacturer asks partial-onset seizure patients to consider switching to a new treatment.
